INTRODUCTION
High-dose treatment with pilocarpine, a cholinergic agonist, results in sustained seizures and status epilepticus accompanied by widespread brain damage in adult rats 20 ,21 . The susceptibility of rats to pilocarpine-induced seizures and status epilepticus is age-dependent" with an adult pattern of behavioral and electrographic seizures encountered in 15-21-day-old rats, while younger animals do not exhibit overt motor seizures. Both lethality and potency of pilocarpine an': increased during the third week of life relative to older and younger animals".
In adult rats the epileptogenic effect of pilocarpine and other muscarinic cholinergic agonist is markedly potentiated by lithium 8 ,10,11,14. Pretreatment with lithium (3 meqykg) 24 h before pilocarpine (30 rngykg) results in EEG and behavioral changes similar to those seen with high dose pilocarpine. We studied the epileptogenic effect of lithium-pilocarpine during ontogenesis in rats in an attempt to determine whether lithium potentiates low doses of pilocarpine in developing animals. In addition we sought to ascertain whether younger animals were more susceptible to lithiumpilocarpine-induced status epilepticus.
MATERIALS AND METHODS

Animals
Six timed-pregnancy Sprague-Dawley rats were obtained from Zivic-Miller, (Zelionple, PA) at the 17th or 18th gestational day. The pregnant animals were housed under a 12-h light/dark cycle, and fed ad libitum. Delivery times were monitored and were accurate to within 12 h. The day of birth was considered day zero. The pups were kept with the mothers, and litters were culled to 12 pups. The groups of animals used in these studies were mixed such that each group contained pups from several litters. The age groups studied included animals of 3-6, 7-10, 11-14, 15-21 and 22-30 postnatal days of age. These age ranges were chosen to reflect the stages of development examined in other studies of the ontogeny of experi- mental seizures in rats 3 ,6,18,22,23. Each pup was drug naive and subjected to lithium-pilocarpine only once.
Drugs
Pilocarpine hydrochloride and lithium chloride were purchased from Sigma (St. Louis, MO, USA), On the day of the experiments the drugs were freshly dissolved in saline (pilocarpine) or water (lithium chloride). Lithium (3 meqykg) was administered intraperitoneally (i.p.) 20 h before pilocarpine which was given subcutaneouslly (s.c.), The volume of injection for both lithium and pilocarpine was 0.1 ml/lO·g body weight. Pilocarpine was administered in doses of 3, 10, 30 or 60 mgykg in order to determine the minimal dose required to induce continuous electrographic and behavioral seizures. There were six animals in each age group for each dose of pilocarpine used.
Surgery and recordings
Animals were anesthetized with halothane and placed in a neonatal rat stereotaxic frame!", Two frontal and two posteroparietal tungsten electrodes were implanted. Depth recordings were obtained from bipolar twist concentric enamel stainless steel electrodes (tip diameter 100 ILm, vertical interelectrode distance 0.5 mrn) placed in the dorsal hippocampus and the nucleus accumbens. The stereotaxic coordinates for these stuctures were derived for each age group from the atlas of Sherwood and Timiras!", The technique allows for EEG recording from freely moving animals, via long, flexible wires'", The surgery was well tolerated. All animals recovered with a normal righting and placing reflex within 2 h of cessation of halothane. 2 h after recovery the pups were treated with lithium chloride, observed for 1 h and returned to the mothers. 20 h later the pups were removed from the litters, baseline EEG recordings made for 30 min, and pilocarpine administered. EEG recordings were made continuously with the animals unrestrained and behavior ob-
121 served for periods ranging from 4 to 6 h following the s.c. administration of pilocarpine.
Histopathological analysis
Animals who survived seizures induced by the lithium-pilocarpine combination were sacrified by decapitation 3 days after the administration of pilocarpine. This was chosen as an arbitrary time period to allow full recovery from the seizures. The brains were processed for pathological examination by light microscopy. 20 ILm coronal frozen sections were stained with hematoxyllin and eosin and examined microscopically to ascertain the presence of brain lesions related to the seizures.
RESULTS
EEG
The results of these experiments are summarized in Table I . In all groups of animals treated with lithium, the baseline EEG was normal for age ( Figs. 1-5 ).
3-6 days (n = 12; Fig 1) . Pilocarpine, 30 and 60 mgykg, failed to induce seizure discharges on EEG. There were no EEG changes that correlated with the behavioral abnormalities noted above in this age group.
7-10 days (n = 12; Fig 2) . Pilocarpine, 30 mg Zkg (n = 6) failed to induce cortical or subcortical seizures; 60 mgykg (n = 4) induced simultaneous cortical and subcortical seizures in all animals with a mean latency d 120miñ duced status epilepticus and showed bilateral synchronous generalized spikes and sharp waves which were of larger amplitude than those seen after seizure in the 7-1O-day-old group. pallidum with subsequent spread to the dorsal hippocampus and cortex. The one animal in this age group which survived the status epilepticus had an abnormal EEG 6 h after pilocarpine administration with bilateral 123 synchronous 1-2 Hz spike and wave and sharp wave discharges. All animals in the group who received 60 mgy'kg pilocarpine developed status epilepticus and died (n = 6).
15-21 days
Behavioral manifestation of seizures
Although these data were analyzed separately from the EEG data, no animal showed behavioral manifestations of seizures or status epilepticus without concomitant electrographic manifestations of seizure. 7-10 days. Pilocarpine 30 mg z'kg (n = 6) induced defecation, continuous scratching and body tremor, but no behavioral seizures; 60 mg z'kg resulted in tonic extension of hind limbs and tail, sustained clonic movements of the forelimbs and loss of postural control in four of the six animals tested. All animals who experienced these seizures survived.
11-14 days. Pilocarpine 10 mgykg (n = 6), induced defecation, salivation, body tremor and scratching in all animals, but no behavioral seizure activity; 30 mgykg induced seizures and status epilepticus in all animals (n = 6). Status epilepticus was defined as sustained orofacial automatisms, salivation, forelimb clonus, and rearing and falling in all animals. All animals survived the status epilepticus induced by 30 mgy'kg. Status epilepticus was observed in all animals at 60 mgy'kg (n = 6), but 4 animals died at this higher dose of pilocarpine 2 h after administration of the drug.
15-21 days.
Pilocarpine, 3 mg z'kg (n = 6) induced no behavioral abnormalities; 10 mgykg (n = 6) induced seizures and status epilepticus in 4 animals similar to that seen in 11-14-day-old animals treated with 30 rngykg of pilocarpine, with all animals surviving. The 30 mg z'kg dose of pilocarpine induced status epilepticus in all 15-21-day-old animals tested (n = 6). Two of these animals died 1 h following administration of pilocarpine; 60 mgykg pilocarpine resulted in status epilepticus and death within 1 h of drug administration in all animals (n = 6).
22-30 days.
Pilocarpine 10 mgy'kg (n = 6) induced defecation, salivation and tremor but no seizures; 30 mgykg induced status epilepticus in all animals. Three animals died within 2 h following the injection of the drug; 60 mgykg resulted in status epilepticus in all animals with death in 5/6 animals within 2 h.
Pathology
Histopathologic examination was done on 24 animals ranging in age from 7 to 30 days. These animals were those described above who experienced lithiumpilocarpine seizures and survived. Light microscopic examination of brain sections taken from these animals failed to reveal any morphological alterations.
DISCUSSION
This study demonstrates that systemic injection of low doses of pilocarpine can induce status epilepticus in developing rats pretreated with lithium.
The cholinergic neuronal network is functional by the end of the second week of life in rats. The concen-125 tration of acetylcholine rises to 29% of adult levels by birth and attains adult levels by 4 weeks postpartum". From 7 to 28 postnatal days of age the specific activity of whole brain choline acetyltransferase increases from 8 to 83% of that found in adult brain", [3H]Quinuclidinyl benzylate, a specific muscarinic agonist, reaches adult levels in the hippocampus at an age of 12-14 days of life", Experimental epileptogenic phenomena mediated by cholinergic mechanisms also appear to be demonstrable by the end of the second week of life. Focal spike discharges induced by intracortical administration of acetylcholine have been reported in 12-day-old rats'". In addition, pilocarpine alone in a dose of 380 mg z'kg induces behavioral and EEG manifestations of status epilepticus in rats during the second week of life 6 • The current study is in agreement with these published data since it suggests that the mechanisms by which lithium potentiates pilocarpine are also in place by the second week of life. There was over a 12-fold potentiation of the epileptogentic effects of pilocarpine by lithium demonstrated in the developing animals which is similar to that published for adults rats".
The proconvulsant effect of lithium is specifically limited to muscarinic cholinergic agonists". However, the way in which lithium exerts this effect remains to be identified. Possible mechanisms include stimulation of acetylcholine synthesis and release!' or inhibition of phosphoinositide hydrolysis-? and/or cyclic AMP production in rat brain".
The susceptibility to lithium-pilocarpine-induced status epilepticus is increased during the third week of life since 15-21-day-old animals treated with pilocarpine 10 mg zkg exhibited status epilepticus while the same dose of pilocarpine failed to induce status epilepticus during the first two weeks of life or in animals older than 21 days. An increased susceptibility to pilocarpine-" and other proconvulsant drugs l ,3,6 during a similar time period has been reported previously although some authors have not observed this developmental window of increased susceptibility to seizure/". One possible explanation for this phenomenon could be related to the precocious development of the excitatory systems within limbic structures and the delayed appearance of inhibitory mechanisms at this age". An alternative explanation for the differential susceptibility of developing animals to pilocarpine after lithium pretreatment may relate to changes in the blood-brain barrier with development. This could be reflected by age-dependent changes in the pharmacokinetics of pilocarpine and/or lithium following systemic administration. Hence the developmental changes observed could reflect differing brain concentrations of lithium and/or pilocarpine achieved in animals of different ages.
Adults rats who survive lithium-pilocarpine-induced status epilepticus have been reported to show widespread brain lesions in the ventral forebrain area? However, we failed to demonstrate any brain lesions in developing animals that experienced lithium-pilocarpine-induced status epilepticus, The literature suggests that immature rats are more resistant to the development of seizure-induced brain damage than adult animals. For example, in the kainic acid model of limbic seizures and status epilepticus no lesions are described until 33-37 days of life'. Pilocarpine alone in rat pups is reported to induce an attenuated pattern of damage compared to that seen in adults. The damage in immature animals treated with high dose pilocarpine is limited to shrinkage of cells and loss of neurons in hippocampus, amygdala, olfactory cortex, neocortex and certain thalamic nuclei". In a model of status epilepticus induced by systemic injection of bicuculIine in three species of young animals, Wasterlain et al. 22 showed that severe status epilepticus produced no ischemic cell necrosis in the immature animals.
In conclusion, we have delineated an electrographic and behavioral model of status epilepticus during the first weeks of postnatal life in rats. This paradigm promises to be a useful model for further investigation of the genesis and propagation of seizures in developing brain.
